Search

Your search keyword '"De Gaetano Donati, Katleen"' showing total 128 results

Search Constraints

Start Over You searched for: Author "De Gaetano Donati, Katleen" Remove constraint Author: "De Gaetano Donati, Katleen"
128 results on '"De Gaetano Donati, Katleen"'

Search Results

1. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

2. Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers: results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24.

3. An Uncommon Manifestation of a Great Imitator: Gummatous Syphilis of the Liver in an HIV‐Positive Patient.

4. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study

7. COVID-19 and intestinal inflammation: Role of fecal calprotectin

9. Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization

10. PREVALENCE OF SEXUALLY TRANSMITTED INFECTIONS AND FACTORS ASSOCIATED WITH HIV STATUS AMONG VULNERABLE WOMEN IN NORTHERN UGANDA: BASELINE RESULTS FROM PE ATYE KENA COHORT STUDY

11. Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering

12. Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study

13. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: the Multicenter Italian CORIST Study

14. Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering

15. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study

16. RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies

17. COVID-19 and intestinal inflammation: Role of fecal calprotectin

18. HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era

19. Assessment of neurological manifestations in hospitalized patients with COVID-19

21. RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies

22. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study

23. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study

28. A pilot experience of common European infectious diseases curriculum for medical students: the IDEAL summer school

29. Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving Highly Active Anti Retroviral Therapy

30. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals

32. The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study

33. Glycopeptide resistance among coagulase- negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study

34. Exposure to abacavir and biomarkers of cardiovascular disease in HIV-1-infected patients on suppressive antiretroviral therapy: a longitudinal study

35. Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma

36. HIV Infection, Antiretroviral Therapy and Cardiovascular Risk

37. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome

39. The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case–control study

42. Exposure to Abacavir and Biomarkers of Cardiovascular Disease in HIV-1–Infected Patients on Suppressive Antiretroviral Therapy

43. Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcome.

44. Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy

45. Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV infected subjects

46. Older HIV-positive patients in the era of highly active antiretroviral therapy: changing a scenario

48. Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome

49. Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapies

50. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome

Catalog

Books, media, physical & digital resources